Date | Detail |
---|---|
Nov 20, 2024 |
Jefferies London Healthcare Conference on Wednesday, November 20th, 2024 at 2:30 pm GMT
|
Sep 05, 2024 |
Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024 at 10:00 am ET
|
Aug 07, 2024 |
Q2 2024 Earnings Materials
|
Jun 11, 2024 |
Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11th, 2024 at 1:20 pm ET
|
May 08, 2024 |
Q1 2024 Earnings Materials
|
Mar 11, 2024 |
Leerink Partners Global Biopharma Conference on Monday, March 11th, 2024 at 10:00 am ET
|
Mar 08, 2024 |
Investor Presentation - Q4 & FY 2023
|
Mar 05, 2024 |
TD Cowen 44th Annual Health Care Conference on Tuesday, March 5th, 2024 at 9:50 am ET
|
Feb 29 - Mar 03, 2024 |
International Congress on Hematologic Malignancies Poster Presentation from Thursday, February 29th thru Sunday, March 3rd: Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-Adjusted Indirect Comparison (MAIC)
|
Jan 08, 2024 |
42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, 2024 at 1:30 pm PST
|
Dec 10, 2023 |
BeiGene 2023 ASH Investor Event on Sunday, December 10th, 2023 at 8:00 pm PST
|
Nov 15, 2023 |
Jefferies London Healthcare Conference on Wednesday, November 15th, 2023 at 2:00 pm GMT
|
Sep 11, 2023 |
Morgan Stanley 21st Annual Global Healthcare Conference
|
Jul 18, 2023 |
BeiGene Investor Research and Development Day on Tuesday, July 18th, 2023 at 8:30am ET
|
June 12, 2023 |
Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12th, 2023 at 11:40 am ET
|
May 31, 2023 |
TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31st, 2023 at 12:00 pm ET
|
Mar 06, 2023 |
Cowen’s 43rd Annual Healthcare Conference on Monday, March 6th, 2023 at 11:10 am ET
|
Feb. 15, 2023 |
The SVB Securities Global Biopharma Conference
|
Feb. 08, 2023 |
The Guggenheim Oncology Conference 2023
|
Jan 9, 2023 |
J.P. Morgan 41st Annual Healthcare Conference 2023
|